Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.51 |
| ▸ | CASP2 | P42575 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 3/20 | 0.45 |
| ▸ | CNR1 | P21554 | 5/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25030622 | 1.00 | EPHX2 (0.53) | EPHX2LPAR1SLC6A5CASP2KDM4E | |
| SCHEMBL12295581 | 0.97 | EPHX2 (0.49) | EPHX2LPAR1SLC6A5CASP2KDM4E | |
| SCHEMBL19935541 | 0.95 | LPAR1 (0.50) | EPHX2LPAR1SLC6A5KDM4EFAAH | |
| SCHEMBL17776037 | 0.91 | EPHX2 (0.56) | EPHX2LPAR1SLC6A5CASP2KDM4E | |
| SCHEMBL31720955 | 0.90 | CNR1 (0.45) | EPHX2LPAR1SLC6A5CASP2FAAH | |
| SCHEMBL23735528 | 0.90 | EPHX2 (0.53) | EPHX2LPAR1SLC6A5CASP2KDM4E | |
| SCHEMBL23760291 | 0.88 | CASP2 (0.47) | EPHX2LPAR1SLC6A5CASP2FAAH | |
| SCHEMBL18973140 | 0.87 | EPHX2 (0.51) | EPHX2LPAR1SLC6A5KDM4EFAAH | |
| SCHEMBL25098992 | 0.86 | EPHX2 (0.69) | EPHX2LPAR1SLC6A5CASP2KDM4E | |
| SCHEMBL10888874 | 0.86 | EPHX2 (0.69) | EPHX2LPAR1SLC6A5CASP2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11660350-B2 | Antibacterial products | UNIVERSITY OF LINCOLN (GB) | 2023-05-30 | — | — | US | disclosed |
| US-20180147290-A1 | NEW ANTIBACTERIAL PRODUCTS | UNIVERSITY OF LINCOLN (GB) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11660350-B2 | Antibacterial products | MSN, VAPA, SLC47A2 | EPHX2 3477/4885LPAR1 3746/4885SLC6A5 3163/4885 |
| US-20180147290-A1 | NEW ANTIBACTERIAL PRODUCTS | MSN, VAPA, VAPB | EPHX2 3882/4885LPAR1 3489/4885SLC6A5 3532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.